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Case report
A 27-year-old Caucasian presented with a major depres-
sion disorder and social phobia since adolescence. The pa-
tient had marked paranoia, auditory hallucinations, extra-
pyramidal dysfunction, poor memory, and gait abnormality. 
Laboratory tests including serum copper and ceruloplasmin 
were all normal. Magnetic resonance imaging (MRI ) ex-
amination of  the brain played an important role in the di-
agnosis of  this patient. 
An MRI scan of  the brain demonstrated central hyperin-
tensity with surrounding hypointense signal in globus palli-
dus, bilaterally suggestive of  "eye of  the tiger" sign on 
FLAIR (Fig. 1) and T2-weighted (Fig. 2) sequences. 
Further clinical and laboratory evaluation revealed a low 
serum pantothenate kinase 2 level, which confirmed the 
diagnosis of  pantothenate kinase 2 defeciency. Subsequent 
supplementation of  pantothenate kinase significantly im-
proved the clinical symptoms.
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Pantothenate kinase 2 deficiency (previously known as Hallervorden-Spatz disease) is an unusual meta-
bolic disorder characterized by progressive extrapyramidal dysfunction and dementia. A 27-year-old 
Caucasian presented with a major depression disorder and social phobia since adolescence. Patient had 
marked paranoia, auditory hallucinations, extrapyramidal dysfunction, poor memory, and gait abnor-
mality. Laboratory tests including serum copper and ceruloplasmin were all normal. Magnetic resonance 
imaging (MRI ) examination of  the brain played an important role in the diagnosis in this patient.
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Figure 1. 27-year-old patient with pantothenate kinase 2 
deficiency. FLAIR-weighted MRI image shows “eye of tiger”  
sign with hyperintense center and hypointense periphery in 
globus pallidus bilaterally.
Discussion
Pantothenate kinase 2 deficiency is an unusual metabolic 
disorder characterized by progressive extrapyramidal dys-
function, dementia, gait impairment, dystonic posturing, 
dysarthria, and loss of  memory. Onset is most common in 
late childhood or early adolescence, but cases with adult 
onset have been described. When the disorder is familial, it 
has autosomal recessive inheritance and has been linked to 
chromosome 20. 
A mutation in the pantothenate kinase (PANK2) gene on 
band 20p13 has been described in patients with typical 
pantothenate kinase 2 deficiency (1). It affects both the 
globus pallidus and the pars reticulata of  the substantia 
nigra in group 1 but involves only the globus pallidus in 
group II (2). The disease can be familial or sporadic. Brain 
autopsy demonstrates symmetric bilateral deposition of  
iron pigment (3). This accounts for the hypointense signal 
on T2-weighted images. The central hyperintense signal is 
related to neuronal loss, demyelination, and reactive gliosis.
Disorders of  iron metabolism can disrupt cell mem-
branes through lack of  antioxidant protection. Nonsense, 
missense, and frameshift mutations in the pantothenate 
kinase gene (PANK2) were detected in HSS patients (4). 
The resulting accumulation of  cysteine in the globus palli-
dus may lead to the chelation and sequestration of  iron. 
Iron plays an important role in the modulation of  certain 
neurotransmitter activities, which are especially associated 
with dopaminergic mechanisms. The gross brain iron ac-
cumulation in HSS and in other neurologic conditions (for 
example, Parkinson's disease and Alzheimer's disease) sug-
gests the possibility that disturbed iron metabolism plays a 
significant primary or secondary role in the pathogenesis of 
these conditions, as well as in others in which iron metabo-
lism is disturbed.
The diagnostic criteria (4) continue to evolve to assess the 
distinctions between PANK and other forms of  neurode-
generation with brain iron accumulation (NBIA). The obli-
gate features have been described as onset during the first 
two decades of  life; progression of  signs and symptoms; 
and evidence of  extrapyramidal dysfunction. The corrobo-
rative features include corticospinal tract involvement (that 
is, spasticity and/or extensor toe signs); progressive intellec-
tual impairment; retinitis pigmentosa and/or optic atrophy; 
seizures; positive family history consistent with autosomal 
recessive inheritance; hypointense areas on MRI involving 
the basal ganglia, particularly the substantia nigra; and 
abnormal cytosomes in circulating lymphocytes and/or 
sea-blue histiocytes in bone marrow.
The following features exclude the diagnosis of  pantho-
thenate kinase 2 deficiency: presence of  abnormal cerulo-
plasmin levels and/or abnormalities in copper metabolism; 
presence of  overt neuronal ceroid-lipofuscinosis (as demon-
strated by severe visual impairment and/or difficult-to-
control seizures, often of  the generalized type), predomi-
nantly epileptic symptoms; severe retinal degeneration or 
visual impairment preceding other symptoms; presence of  
familial history of  Huntington's chorea and/or other auto-
somal dominantly inherited neuromovement disorder; 
presence of  caudate atrophy as demonstrated by imaging 
studies; nonprogressive course; and absence of  extrapyra-
midal signs. 
Pantothenate kinase was originally described by Haller-
vorden and Spatz and is also known as Hallervorden-Spatz 
disease. However, since Hallervorden and Spatz were 
closely associated with Nazi extermination policies (5), re-
cently pantothenate kinase 2 deficiency has become the 
preferred term for this entity.
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Figure 2. 27-year-old patient with pantothenate kinase 2 
deficiency. T2-weighted MRI image shows “eye of tiger” 
sign with hyperintense center and hypointense periphery in 
globus pallidus bilaterally.
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